Copyright © 1998 by the European Society of Cardiology.
Improved long term prognosis after myocardial infarction 19841991
Department of Medicine, Östra University Hospital, Göteborg, Sweden
accepted February 25, 1998
Aims We set out to examine whether long term prognosis in terms of 2-year mortality after myocardial infarction has improved after the introduction of intravenous beta-blockers, nitroglycerin infusion, aspirin and thrombolytics, in an unselected population of patients hospitalized with a myocardial infarction.
Methods and Results We investigated retrospectively 3791 acute myocardial infarctions in 3187 Göteborg women and men (1039 women and 2148 men), who were consecutively admitted to the coronary care unit at the Östra hospital during 19841991. Throughout this period, data were entered continuously into the coronary care unit database. Mortality data were collected through the Swedish cause-specific mortality register. The primary end-point was mortality within 2 years after the onset of the index infarction. Two-year mortality decreased from 36% in 1984 to 25% in 1991. In a Cox regression model (including myocardial infarctions up to 1993) year of hospitalization, age, diabetes mellitus, sex, prior myocardial infarction and indeterminable infarct location all had a significant impact on survival after myocardial infarct. Thrombolytic therapy and hypertension had no prognostic significance.
Conclusion Against a background of radical changes in the treatment of acute myocardial infarction during 1984 1991 we have seen decreasing in-hospital mortality as well as a substantial decrease in 2-year mortality.
Key Words: Myocardial infarction, prognosis, thrombolytic therapy
f1 Correspondence: P. Abrahamsson, Department of Medicine, Sahlgrenska Universitetssjukhuset/Östra, 416 86 Göteborg, Sweden.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf CHAPTER 16 Acute Coronary Syndromes ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Huovinen, T. Harkanen, T. Martelin, S. Koskinen, and A. Aromaa Predicting coronary heart disease mortality--assessing uncertainties in population forecasts and death probabilities by using Bayesian inference Int. J. Epidemiol., October 1, 2006; 35(5): 1246 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kattainen, V. Salomaa, T. Harkanen, A. Jula, R. Kaaja, Y. A. Kesaniemi, M. Kahonen, L. Moilanen, M. S. Nieminen, A. Aromaa, et al. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s Eur. Heart J., February 1, 2006; 27(3): 296 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schaufelberger, K. Swedberg, M. Koster, M. Rosen, and A. Rosengren Decreasing one-year mortality and hospitalization rates for heart failure in Sweden: Data from the Swedish Hospital Discharge Registry 1988 to 2000 Eur. Heart J., February 2, 2004; 25(4): 300 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kattainen, A. Reunanen, S. Koskinen, T. Martelin, P. Knekt, and A. Aromaa Secular changes in prevalence of cardiovascular diseases in elderly Finns Scand J Public Health, October 1, 2002; 30(4): 274 - 280. [Abstract] [PDF] |
||||
![]() |
J.C. Kaski Treatment of stable angina pectoris: is there a role for dipyridamole? Eur. Heart J., October 1, 2001; 22(19): 1762 - 1764. [PDF] |
||||
![]() |
S Capewell, B.M Livingston, K MacIntyre, J.W.T Chalmers, J Boyd, A Finlayson, A Redpath, J.P Pell, C.J Evans, and J.J.V McMurray Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland Eur. Heart J., November 2, 2000; 21(22): 1833 - 1840. [Abstract] [PDF] |
||||
![]() |
C.K. Dyke and R.M. Calif National and regional registries: what good are they? Eur. Heart J., September 1, 2000; 21(17): 1401 - 1403. [PDF] |
||||
![]() |
P Abrahamsson, A Rosengren, and M Dellborg Improved long-term prognosis for patients with unstable coronary syndromes 1988-1995 Eur. Heart J., April 1, 2000; 21(7): 533 - 539. [Abstract] [PDF] |
||||
![]() |
S Gottlieb, U Goldbourt, V Boyko, D Harpaz, L Mandelzweig, Z Khoury, S Stern, S Behar, and for the SPRINT and Israeli Thrombolytic Survey Gro Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994 Eur. Heart J., February 2, 2000; 21(4): 284 - 295. [Abstract] [PDF] |
||||



